Kyverna Therapeutics (San Diego)

Overview

Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing clinical trials across multiple autoimmune conditions.

Part of the San Diego ecosystem

Related

• Altos LabsDevelops medicines based on cell rejuvenation, using computation, machine learning, and internal and external biological data to study cell health, disease, injury, and disability.
• Artiva Biotherapeutics ($ARTV)Develops off-the-shelf, non-genetically modified natural killer cell therapies for deep B-cell depletion, aiming to help patients with autoimmune diseases such as rheumatoid arthritis.
• Bristol Myers Squibb (San Diego)Develops medicines through biopharmaceutical research, clinical trials, and product development, providing medical information and support resources for patients and healthcare providers.
• Cell & Gene Meeting on the MesaBrings executives and decision-makers together to address cell and gene therapy commercialization challenges through panels, presentations, networking, and one-on-one partnering meetings.
• Forward VenturesInvests across company stages in biopharmaceutical therapeutics, supporting founders and management with resources for hiring, strategy, financing, IPO preparation, and exits.
• Halozyme Therapeutics ($HALO)Develops subcutaneous drug delivery technologies, commercializes approved products using them, and partners with pharmaceutical companies needing injection platforms, auto-injectors, and multi-dose pens.
• Iambic TherapeuticsBuilds AI-driven drug discovery technologies and experimental platforms to design molecular candidates and generate biological data for therapeutic pipelines and partners.
• Illumina ($ILMN)Provides sequencing and array systems, reagents, software, services, financing, and training for laboratories and researchers conducting genomic discovery and analysis workflows.
• Poseida Therapeutics (Roche)Develops cell therapy candidates and related platform technologies, with legacy programs in a biotechnology pipeline for medicines targeting serious and life-threatening diseases.
• Salk Institute for Biological StudiesConducts foundational collaborative biological research on challenges such as cancer, Alzheimer’s disease, and crop resilience, while offering architecture tours and student science outreach.
• Sanford Burnham PrebysConducts biomedical research through disease-focused centers, advancing discoveries toward treatments for cancer, neurologic, metabolic, liver, heart and muscle diseases while training scientists.
• Vertex Pharmaceuticals (San Diego)Discovers, develops, and produces medicines for serious diseases, while providing medical information, patient support, and clinical trial opportunities for treatment research participants.